Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 10/2013

01-12-2013

Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients

Auteurs: Carlos K. H. Wong, Elegance T. P. Lam, Cindy L. K. Lam

Gepubliceerd in: Quality of Life Research | Uitgave 10/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The short form six dimensions (SF-6D) are derived from the SF-36 Health Survey with the intention that item data of the latter are often converted to a preference value, which was subsequently used in economic evaluations of interventions. The aim was to compare the equivalence and sensitivity of health preference values derived from the SF-36/SF-12 Health Surveys to that measured directly by the SF-6D for chronic hepatitis B (CHB) patients.

Methods

This was a secondary analysis of the SF-6D and SF-36 data from a baseline sample of 589 patients with CHB infection with different stages of liver diseases. Degree of agreement (equivalence) between direct-measured and derived SF-6D values was determined using spearman correlation and intra-class correlation. Sensitivity and discriminative power of different SF-6D values were compared by standardized effect size and relative efficiency (RE) statistics.

Results

Significant differences in the direct-measured or derived SF-6D preference values were found between CHB groups. Degree of agreement between SF-6D values was satisfactory. Direct-measured SF-6D was the most efficient, followed by SF-12-derived and the SF-36-derived was the least, based on the standardized effect size and the RE statistics. Sensitivity and discriminative power of direct-measured SF-6D were superior to derived SF-6D among people with different CHB health states.

Conclusions

Although direct-measured and derived SF-6D preference values had satisfactory sensitivity in discriminating between CHB groups, direct-measured SF-6D is the most sensitive and preferable method of obtaining health preference.
vorige artikel A comparison of directly elicited and pre-scored preference-based measures of quality of life: the case of adhesive capsulitis
volgende artikel Measuring health-related quality of life among adults in Singapore: population norms for the EQ-5D
Literatuur
1.
World Health Organization. (1996). World health report 1996: Fighting disease, fostering development. Geneva: World Health Organization.CrossRef
2.
Lam, E. T. P., Lam, C. L. K., Lai, C. L., Yuen, M. F., Fong, D. Y. T., & So, T. (2009). Health-related quality of life of southern Chinese with chronic hepatitis B infection. Health and Quality of Life Outcomes, 7(1), 52.PubMedCrossRef
3.
Levy, A. R., Kowdley, K. V., Iloeje, U., Tafesse, E., Mukherjee, J., Gish, R., et al. (2008). The impact of chronic hepatitis B on quality of life: A multinational study of utilities from infected and uninfected persons. Value in Health, 11(3), 527–538.PubMedCrossRef
4.
Dan, A. A., Kallman, J. B., Srivastava, R., Younoszai, Z., Kim, A., & Younossi, Z. M. (2008). Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index. Liver Transplantation, 14(3), 321–326.PubMedCrossRef
5.
Ong, S. C., Mak, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.PubMedCrossRef
6.
Bondini, S., Kallman, J., Dan, A., Younoszai, Z., Ramsey, L., Nader, F., et al. (2007). Health-related quality of life in patients with chronic hepatitis B. Liver International, 27(8), 1119–1125.PubMedCrossRef
7.
Saab, S., Ibrahim, A. B., Surti, B., Durazo, F., Han, S., Yersiz, H., et al. (2008). Pretransplant variables associated with quality of life in liver transplant recipients. Liver International, 28(8), 1087–1094.PubMedCrossRef
8.
EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
9.
Torrance, G., Feeny, D., Furlong, W., Barr, R., Zhang, Y., & Wang, Q. (1996). Multiattribute utility function for a comprehensive health status classification system: Health utilities index mark 2. Medical Care, 34(7), 702–722.PubMedCrossRef
10.
Feeny, D., Furlong, W., Torrance, G., Goldsmith, C., Zhu, Z., DePauw, S., et al. (2002). Multi-attribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.PubMedCrossRef
11.
Brazier, J., Usherwood, T., Harper, R., & Thomas, K. (1998). Deriving a preference-based single index from the UK SF-36 health survey. Journal of Clinical Epidemiology, 51(11), 1115–1128.PubMedCrossRef
12.
Longworth, L., & Bryan, S. (2003). An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Economics, 12(12), 1061–1067.PubMedCrossRef
13.
Bryce, C. L., Angus, D. C., Switala, J., Roberts, M. S., & Tsevat, J. (2004). Health status versus utilities of patients with end-stage liver disease. Quality of Life Research, 13(4), 773–782.PubMedCrossRef
14.
Thein, H. H., Krahn, M., Kaldor, J. M., & Dore, G. J. (2005). Estimation of utilities for chronic hepatitis C from SF-36 scores. The American Journal of Gastroenterology, 100(3), 643–651.PubMedCrossRef
15.
Björnsson, E., Verbaan, H., Oksanen, A., Frydén, A., Johansson, J., Friberg, S., et al. (2009). Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scandinavian Journal of Gastroenterology, 44(7), 878–887.PubMedCrossRef
16.
Younossi, Z. M., Boparai, N., McCormick, M., Price, L. L., & Guyatt, G. (2001). Assessment of utilities and health-related quality of life in patients with chronic liver disease. The American Journal of Gastroenterology, 96(2), 579–583.PubMedCrossRef
17.
Hsu, P. C., Federico, C. A., Krajden, M., Yoshida, E. M., Bremner, K. E., Anderson, F. H., et al. (2012). Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 27(1), 149–157.PubMedCrossRef
18.
Chong, C. A. K. Y., Gulamhussein, A., Heathcote, E. J., Lilly, L., Sherman, M., Naglie, G., et al. (2003). Health-state utilities and quality of life in hepatitis C patients. The American Journal of Gastroenterology, 98(3), 630–638.PubMedCrossRef
19.
Gutteling, J. J., De Man, R. A., Van Der Plas, S. M., Schalm, S. W., Busschbach, J. J. V., & Darlington, A. S. E. (2006). Determinants of quality of life in chronic liver patients. Alimentary Pharmacology & Therapeutics, 23(11), 1629–1635.CrossRef
20.
Russell, R. T., Feurer, I. D., Wisawatapnimit, P., & Pinson, C. W. (2009). The validity of EQ-5D US preference weights in liver transplant candidates and recipients. Liver Transplantation, 15(1), 88–95.PubMedCrossRef
21.
Ratcliffe, J., Longworth, L., Young, T., Bryan, S., Burroughs, A., & Buxton, M. (2002). Assessing health-related quality of life pre- and post-liver transplantation: A prospective multicenter study. Liver Transplantation, 8(3), 263–270.PubMedCrossRef
22.
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRef
23.
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.PubMedCrossRef
24.
McDonough, C. M., Grove, M. R., Tosteson, T. D., Jon, D. L., Hilibrand, A. S., & Tosteson, A. N. A. (2005). Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) Participants. Quality of Life Research, 14(5), 1321–1332.PubMedCrossRef
25.
Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.PubMedCrossRef
26.
Lamers, L. M., Bouwmans, C. A. M., Straten, Av, Donker, M. C. H., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15(11), 1229–1236.PubMedCrossRef
27.
Barton, G. R., Sach, T. H., Avery, A. J., Jenkinson, C., Doherty, M., Whynes, D. K., et al. (2008). A comparison of the performance of the EQ-5D and SF-6D for individuals aged ge 45 years. Health Economics, 17(7), 815–832.PubMedCrossRef
28.
Konerding, U., Moock, J., & Kohlmann, T. (2009). The classification systems of the EQ-5D, the HUI II and the SF-6D: What do they have in common? Quality of Life Research, 18(9), 1249–1261.PubMedCrossRef
29.
Lam, E. T. P., Lam, C. L. K., Lai, C. L., Yuen, M. F., & Fong, D. Y. T. (2009). Psychometrics of the chronic liver disease questionnaire for southern Chinese patients with chronic hepatitis B virus infection. World Journal of Gastroenterology, 15(26), 3288–3297.PubMedCrossRef
30.
Ware, J. E, Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef
31.
Ware, J. E., Snow, K., Kosinski, J. M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New English Medical Centre.
32.
Lam, C. L. K., Gandek, B., Ren, X. S., & Chan, M. S. (1998). Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 health survey. Journal of Clinical Epidemiology, 51(11), 1139–1147.PubMedCrossRef
33.
Lam, C. L. K., Tse, E. Y. Y., & Gandek, B. (2005). Is the standard SF-12 health survey valid and equivalent for a Chinese population? Quality of Life Research, 14(2), 539–547.PubMedCrossRef
34.
Lam, C. L. K., Lauder, I., Lam, T. P., & Gandek, B. (1999). Population based norming of the Chinese (HK) version of the SF-36 health survey. Hong Kong Practitioner, 21(10), 460–470.
35.
Lam, C. L. K., Wong, C. K. H., Lam, E. T. P., Lo, Y. Y. C., & Huang, W. W. (2010). Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner, 32, 77–86.
36.
McGhee, S. M., Brazier, J., Lam, C. L. K., Wong, L. C., Chau, J., Cheung, A., et al. (2011). Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(Suppl 6), 17–21.PubMed
37.
Lam, C. L. K., Brazier, J., & McGhee, S. M. (2008). Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value in Health, 11(2), 295–303.PubMedCrossRef
38.
Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.PubMedCrossRef
39.
Luo, N., Johnson, J. A., Shaw, J. W., & Coons, S. J. (2009). Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States. Medical Care, 47(1), 53–60.PubMedCrossRef
40.
Whitfield, K., Buchbinder, R., Segal, L., & Osborne, R. (2006). Parsimonious and efficient assessment of health-related quality of life in osteoarthritis research: Validation of the assessment of quality of life (AQoL) instrument. Health and Quality of Life Outcomes, 4(1), 19.PubMedCrossRef
41.
Mutebi, A., Brazier, J., & Walters, S. (2011). A comparison of the discriminative and evaluative properties of the SF-36 and the SF-6D index. Quality of Life Research, 20(9), 1477–1486.PubMedCrossRef
42.
Luo, N., Wang, P., Fu, A. Z., Johnson, J. A., & Coons, S. J. (2012). Preference-based SF-6D scores derived from the SF-36 and SF-12 have different discriminative power in a population health survey. Medical Care, 50(7), 627–632.PubMedCrossRef
43.
Pickard, A. S., Yang, Y., & Lee, T. (2011). Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes, 9(1), 26.PubMedCrossRef
44.
Zhao, F. L., Yue, M., Yang, H., Wang, T., Wu, J. H., & Li, S. C. (2010). Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients. Value in Health, 13(5), 649–656.PubMedCrossRef
45.
Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.PubMedCrossRef
46.
Wong, C. K. H., Mulhern, B., Wan, Y. F., & Lam, C. (Under review). Responsiveness of preference-based quality of life measure was improved by mapping algorithm in colorectal cancer.
47.
Cheung, Y. B., Wong, L. C., Tay, M. H., Toh, C. K., Koo, W. H., Epstein, R., et al. (2004). Order effects in the assessment of quality of life in cancer patients. Quality of Life Research, 13(7), 1217–1223.PubMedCrossRef
Metagegevens
Titel
Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients
Auteurs
Carlos K. H. Wong
Elegance T. P. Lam
Cindy L. K. Lam
Publicatiedatum
01-12-2013
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 10/2013
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0403-z

Andere artikelen Uitgave 10/2013

Quality of Life Research 10/2013 Naar de uitgave

OriginalPaper

Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form

OriginalPaper

Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician’s attention

OriginalPaper

Self-esteem and life satisfaction in adolescents—gender and age as potential moderators

OriginalPaper

Development of a paper-and-pencil semi-adaptive questionnaire for 5 domains of health-related quality of life (PAT-5D-QOL)

OriginalPaper

Examination of the construct validity of the Swedish version of Hospital Anxiety and Depression Scale in breast cancer patients

Review

Using patient-reported measurement to pave the path towards personalized medicine